In fresh trouble for Indian pharma company Marion Biotech, the World Health Organisation has recommended against use of its products in Uzbekistan.
The global health body said on 11 January 2023 that two cough syrups made by the Noida-based company should not be used for children in Uzbekistan. The WHO said that Marion's "substandard" medical products "fail to meet quality standards or specifications".
The two cough syrups are AMBRONOL and DOK-1 Max.
The recommendation follows reports of children dying after consuming the cough syrups in Uzbekistan.
Also Watch: Indian cough syrup under scanner after 66 children die in Gambia: WHO